首页|期刊导航|Genes & Diseases|Single-cell RNA sequencing and large-panel NGS analysis reveal transcriptional heterogeneity and genomic characteristics of double primary lung cancer and thyroid cancer

Single-cell RNA sequencing and large-panel NGS analysis reveal transcriptional heterogeneity and genomic characteristics of double primary lung cancer and thyroid cancerOA

中文摘要

Double primary malignant tumors refer to the presence of two independent primary malignancies in the same or different organs.In recent years,the detection rate of double primary malignant tumors has significantly increased,of which double primary cancers related to lung cancer account for 10%–15%.This is mainly due to the increase in the incidence rate of lung cancer,the long-term side effects of chemotherapy or radiation therapy,and continuous innovations in cancer-related detection techniques.However,research on double primary malignant tumors(such as lung cancer and thyroid cancer:DPLT)involving lung cancer is still limited.The lack of experimental evidence and clinical data related to double primary tumors,especially the unique genomic and transcriptome characteristics,poses difficulties for the prevention and treatment of double primary tumors.In this study,we used single-cell RNA sequencing and large-panel sequencing to investigate multiomics changes during DPLT progression and revealed their gene mutation characteristics and tumor microenvironment heterogeneity,thereby providing novel insights for clinical detection and therapeutic strategies in DPLT patients.

Erteng Jia;Lixia Zhang;Yong Ge;Li Li;He Zhang;Hao Zhang

Thoracic Surgery Laboratory,The First College of Clinical Medicine,Xuzhou Medical University,Xuzhou,Jiangsu 221006,ChinaThoracic Surgery Laboratory,The First College of Clinical Medicine,Xuzhou Medical University,Xuzhou,Jiangsu 221006,ChinaThoracic Surgery Laboratory,The First College of Clinical Medicine,Xuzhou Medical University,Xuzhou,Jiangsu 221006,China Department of Thoracic Surgery,Affiliated Hospital of Xuzhou Medical University,Xuzhou,Jiangsu 221006,ChinaThoracic Surgery Laboratory,The First College of Clinical Medicine,Xuzhou Medical University,Xuzhou,Jiangsu 221006,ChinaThe College of Life Sciences,Xuzhou Medical University,Jiangsu 221006,ChinaThoracic Surgery Laboratory,The First College of Clinical Medicine,Xuzhou Medical University,Xuzhou,Jiangsu 221006,China Department of Thoracic Surgery,Affiliated Hospital of Xuzhou Medical University,Xuzhou,Jiangsu 221006,China

医药卫生

lung cancerdouble primary cancersSingle cell RNA sequencinglung cancertheradiation therapyandLarge panel NGS analysisTranscriptional heterogeneitydouble primary malignant tumors

《Genes & Diseases》 2026 (4)

P.32-35,4

supported by funds from the National Natural Science Foundation of China(No.82472885 to HaoZhang,82500535 to Erteng Jia and 82300521 to He Zhang)the Noncommunicable Chronic Diseases-National Scienceand Technology Major Project(No.2024ZD0529400 and 2024ZD0529405 to Hao Zhang)the Social Development Projects of Key R&D Programs in Xuzhou City(No.KC22097to Hao Zhang)the XZHMU-QL Joint Research Fund(No.QLYB018 to Erteng Jia)the Natural Science Foundation of the Jiangsu Higher Education Institutions of China(25KJD310003 to Erteng Jia)the Xuzhou Medical University 2022 Scientific Research Launch Fund for Introducing High level Talents(No.D2022016 to Erteng Jia).

10.1016/j.gendis.2025.101889

评论